Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Clinical trial NCT00327288 · COMPLETED

Trial details

NCT number: NCT00327288
Sponsor: AmpliMed Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Breast Cancer Prostate Cancer

Start date: 2005-10-01
Primary completion: 2008-07-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.